|

Treatment of Menstrual Cycle Alterations in Adolescents

RECRUITINGN/ASponsored by Lo.Li.Pharma s.r.l
Actively Recruiting
PhaseN/A
SponsorLo.Li.Pharma s.r.l
Started2025-06-01
Est. completion2026-06
Eligibility
Age14 Years – 19 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06800170

Summary

the aim of the present study is intended to evaluate how treatment with Myo-Inositol and Dioscorea Villosa can help improve menstrual cycle irregularities in adolescents, both with and without PCOS.

Eligibility

Age: 14 Years – 19 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* adolescent women aged 14-19 years old, with at least 3 years passed after menarche, and oligomenorrhea or amenorrhea

Exclusion Criteria:

* Primary amenorrhea.
* Hyperandrogenism due to other factors (i.e. adrenal hyperplasia or Cushing syndrome).
* Hyperprolactinemia or overt hypothyroidism (TSH ≥4).
* Other hormonal alterations.
* Ongoing hormonal therapies, including OCPs, six months before enrollment.
* Ongoing pharmacological therapies.
* Ongoing use of myo-Inositol supplement or other source of myo-Inositol, or Dioscorea villosa, six months before enrollment.

Conditions4

AmenorrheaCancerOligomenorrheaPCOS (Polycystic Ovary Syndrome)

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.